Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Intravenous contrast media].

T Aakhus

    Nordisk Medicin
    |January 1, 1989
    PubMed
    Summary
    This summary is machine-generated.

    Traditional contrast media cause adverse events in 5-7% of patients. Newer, safer contrast agents are increasingly used despite higher costs, offering pharmacological advantages.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Medical radiology in Norway.

    Acta radiologica (Stockholm, Sweden : 1987)·1996
    Same author

    [100 years of medical radiology--development in Norway].

    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·1995
    Same author

    Cerebral thromboembolic complications associated with the use of a nonionic contrast medium in coronary angiography.

    Acta radiologica (Stockholm, Sweden : 1987)·1995
    Same author

    Heart volume and cardiovascular mortality. A 16 year follow-up study of 1984 healthy middle-aged men.

    European heart journal·1993
    Same author

    [Iodixanol. A new isotonic x-ray contrast medium].

    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·1991
    Same author

    Experience with iodixanol, a new nonionic dimeric contrast medium. Preliminary results from the human phase I study.

    Investigative radiology·1990
    Same journal

    [Nordisk Medicine 1929-1998. Thanks and farewell!].

    Nordisk medicin·1999
    Same journal

    [Scientific fraud and misconduct--need for comprehensive terminology].

    Nordisk medicin·1999
    Same journal

    [Labor-market for Scandinavian physicians in the year 2000--dearth or surplus?].

    Nordisk medicin·1999
    Same journal

    [Internet in consultation--headed for trouble?].

    Nordisk medicin·1999
    Same journal

    [Interpretation of questionnaires. An translation method problem].

    Nordisk medicin·1999
    Same journal

    [Assessment of patients' health status--review of the literature and assessment methods].

    Nordisk medicin·1999
    See all related articles

    Area of Science:

    • Pharmacology
    • Radiology

    Context:

    • Intravenous contrast media are widely used in medical imaging.
    • Traditional contrast agents are associated with a 5-7% incidence of adverse events.
    • Certain conditions and procedures increase the risk and severity of reactions.

    Purpose:

    • To review the adverse event profiles of traditional and newer contrast media.
    • To discuss the pharmacological benefits and cost implications of alternative contrast agents.

    Summary:

    • Newer contrast media exhibit a lower incidence of adverse reactions compared to traditional agents.
    • Despite higher acquisition costs, the utilization of these advanced contrast media is progressively rising.
    • Pharmacological improvements in newer agents are driving their adoption in clinical practice.

    Related Experiment Videos

    Impact:

    • Enhanced patient safety through reduced adverse events.
    • Potential for improved diagnostic accuracy and patient outcomes with safer agents.
    • Shifting market trends favor the adoption of advanced contrast media in healthcare settings.